摘要
目的:观察2种用药方案治疗十二指肠溃疡(DU)的临床疗效,并进行成本-效果分析。方法:80例DU患者随机分为A组(奥美拉唑+胶体果胶铋+阿莫西林)与B组(奥美拉唑+克拉霉素+阿莫西林),各40例,疗程结束后复查胃镜,观察溃疡愈合率、临床症状缓解情况及成本-效果比。结果:A、B组镜下溃疡愈合率分别为100·00%、87·50%(P<0·05),药物总成本分别为182·74、314·08元,成本-效果比分别为182·74、358·95;与A组比较,B组增量成本-效果比为—1050·72。结论:A组用药方案治疗DU效果好,成本低,值得推广。
OBJECTIVE:To observe the clinical efficacy of omeprazole plus colloidal bismuth pectin and amoxicillin in the treatment of duodenal ulcer(DU) and on which a cost - effectiveness analysis was performed.METHODS:80 patients with DU were randomly assigned to receive omeprazole + colloidal bismuth pectin + amoxicillin(Group A, n = 40) or omeprazole + clar-ithromycin + amoxicillin(Group B, n = 40) .After the completion of treatment, gastroscopic examination was performed to observe the cure rate of DU and the improvement of clinical symptoms.The cost - effectiveness ratios were compared.RESULTS: In the two groups(A vs. B), the cure rates under gastroscope were 100.00% vs.87.50% (P〈0.05), the total drug costs were 182.74 yuan vs. 314.08 yuan, the cost- effectiveness ratios were 182.74 vs. 358.95, respectively.As compared with Group A, the incremental cost- effectiveness ratio of Group B was -1 050.72. CONCLUSION: The therapy of omeprazole + colloidal bismuth pectin + amoxicillin was proved to be effective in the treatment of DU yet at a low cost, which thus deserves to be popularized in the clinic.
出处
《中国药房》
CAS
CSCD
北大核心
2008年第8期561-562,共2页
China Pharmacy